Market closedNon-fractional

MiMedx Group/MDXG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About MiMedx Group

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Ticker

MDXG

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Marietta, United States

Employees

895

MiMedx Group Metrics

BasicAdvanced
$1.1B
Market cap
16.13
P/E ratio
$0.44
EPS
1.43
Beta
-
Dividend rate
$1.1B
1.43
3.289
2.499
11.849
12.491
7.55%
16.26%
68.13%
16.135
2.665
6.76
8.51
25.989
19.20%
-259.85%
10.72%
-18.43%

What the Analysts think about MiMedx Group

Analyst Ratings

Majority rating from 5 analysts.
Buy

MiMedx Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.86% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$85M
-2.42%
Net income
$9.2M
-82.77%
Profit margin
10.86%
-82.35%

MiMedx Group Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 55.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-
$0.06
$0.32
$0.07
-
Expected
-$0.02
$0.05
$0.07
$0.05
$0.08
Surprise
-
33.33%
357.14%
55.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for MiMedx Group stock?

MiMedx Group (MDXG) has a market cap of $1.1B as of July 23, 2024.

What is the P/E ratio for MiMedx Group stock?

The price to earnings (P/E) ratio for MiMedx Group (MDXG) stock is 16.13 as of July 23, 2024.

Does MiMedx Group stock pay dividends?

No, MiMedx Group (MDXG) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next MiMedx Group dividend payment date?

MiMedx Group (MDXG) stock does not pay dividends to its shareholders.

What is the beta indicator for MiMedx Group?

MiMedx Group (MDXG) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell MiMedx Group stock

Buy or sell MiMedx Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing